Dismissed
The Board dismissed the appeal regarding the proposed reduction in rating for residuals of low grade papillary urothelial carcinoma with prostate cancer as there was no final agency action subject to appeal.
The deciding factor: There was no final decision resulting in a reduction, and the June 2025 rating decision was only a proposal not subject to appeal.
- Claimed conditions
- Not specified in this decision
- How they argued it
- Not specified
- Exposure basis
- None
- Rating assigned
- None in this decision
- Decision date
- October 9, 2025
- Citation
- A25087476
Want to see how appeals like this one tend to go? Appeals like mine
We are not the VA. Veterans’ Rights is an independent resource built for veterans. We are not the U.S. Department of Veterans Affairs, not part of the government, and not endorsed by any government agency.
This is general information, not legal advice. For advice about your own situation, talk to a VA-accredited representative — many help for free.